AstraZeneca (AZN) enters a settlement with Handa Pharmaceuticals in a patent infringement case...


AstraZeneca (AZN) enters a settlement with Handa Pharmaceuticals in a patent infringement case over Handa's proposed Seroquel extended-release tablets. Under the terms of the agreement, Handa can enter the U.S. market with the drug in November 2016 or earlier in certain circumstances.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs